Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: A gynecologic oncology group study

Agustin A. Garcia^*, John A. Blessing, Kathleen M. Darcy, Heinz Josef Lenz, Wu Zhang, Ed Hannigan, David H. Moore

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review